Menu utilisateur

Accès à distance ? S'identifier sur le proxy UCLouvain

Rechercher

Affichage: 5 résultats.
    • Article de périodique
    Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial.
    Coiffier, Bertrand Osmanov, Evgenii A Hong, Xiaonan Scheliga, Adriana Mayer, Jiri Offner, Fritz Rule, Simon Teixeira, Adriana Walewski, Jan de Vos, Sven Crump, Michael Shpilberg, Ofer Esseltine, Dixie-Lee Zhu, Eugene Enny, Christopher Theocharous, Panteli van de Velde, Helgi Elsayed, Yusri A Zinzani, Pier Luigi André, Marc[UCL] (2011) The Lancet Oncology — Vol. 12, no.8, p. 773-84 (2011)
    • Article de périodique
    Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.
    Chanan-Khan, Asher Cramer, Paula Demirkan, Fatih Fraser, Graeme Silva, Rodrigo Santucci Grosicki, Sebastian Pristupa, Aleksander Janssens, Ann Mayer, Jiri Bartlett, Nancy L Dilhuydy, Marie-Sarah Pylypenko, Halyna Loscertales, Javier Avigdor, Abraham Rule, Simon Villa, Diego Samoilova, Olga Panagiotidis, Panagiots Goy, Andre Mato, Anthony HELIOS investigators Van Den Neste, Eric[UCL] (2016) The Lancet Oncology — Vol. 17, no. 2, p. 200-211 (2016)
    • Article de périodique
    Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMT.
    Nabergoj, Mitja Mauff, Katya Robin, Marie Kröger, Nicolaus Angelucci, Emanuele Poire, Xavier[UCL] Passweg, Jakob Radujkovic, Aleksandar Platzbecker, Uwe Robinson, Stephen Rambaldi, Alessandro Petersen, Søren Lykke Stölzel, Fridrich Stelljes, Matthias Ciceri, Fabio Mayer, Jiri Ladetto, Marco de Wreede, Liesebeth C Koster, Linda Hayden, Patrick J Czerw, Tomasz Hernández-Boluda, Juan Carlos McLornan, Donal Chalandon, Yves Yakoub-Agha, Ibrahim (2021) Bone marrow transplantation — Vol. 56, no. 8, p. 1944-1952 (2021)
    • Article de périodique
    Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT.
    Garderet, Laurent Sbianchi, Giulia Iacobelli, Simona Blaise, Didier Byrne, Jenny L Remenyi, Peter Apperley, Jane F Touzeau, Cyrille Isaksson, Cecilia Browne, Paul Mayer, Jiri Lenhoff, Stig Gonzalez Muniz, Soledad Parody Porras, Rocio Basak, Grzegorz Poire, Xavier[UCL] Trneny, Marek Nagler, Arnon Michieli, Mariagrazia Tanase, Alina Koster, Linda Hayden, Patrick J Beksac, Meral Schönland, Stefan Yakoub-Agha, Ibrahim (2021) European journal of haematology — Vol. 106, no. 5, p. 708-715 (2021)
    • Article de périodique
    Exploratory Analysis of Factors Influencing Efficacy and Safety of Camidanlumab Tesirine: Data from the Open-Label, Multicenter, Phase 2 Study of Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (R/R cHL)
    Herrera, Alex F. Ansell, Stephen M. Zinzani, Pier Luigi Radford, John Maddocks, Kami J. Pinto, Antonio Collins, Graham P. Bachanova, Veronika Bartlett, Nancy L. Bence-Bruckler, Isabelle Hamadani, Mehdi Kline, Justin Mayer, Jiri Savage, Kerry J. Advani, Ranjana H. Caimi, Paolo F. Casasnovas, René-Olivier Feldman, Tatyana A. Hess, Brian T. Bastos-Oreiro, Mariana Iyengar, Sunil Szomor, Árpád Townsend, William André, Marc[UCL] Dyczkowski, Jerzy Eisen, Sandy Urban, Andrzej Pantano, Serafino Cruz, Hans G. Wang, Luqiang Negievich, Yanina Wuerthner, Jens Carlo-Stella, Carmelo (2022) Blood — Vol. 140, no.Supplement 1, p. 3673-3677 (2022)